ESTA: Establishment Labs Forward P/E Multiple

Graphic logo of establishmentlabs.com (ESTA)

The forward P/E of Establishment Labs (ESTA) reflects market expectations, with the current metric standing at 0.00. This trend is driven by the high margins of Motiva implants, which ensure a stable cash flow. However, demand for aesthetics is sensitive to economic downturns, creating revenue volatility. Raw material supply risks are minimized by building reserves of high-quality silicone from trusted partners.

establishmentlabs.com - ESTA Price to Expected Earnings Ratio (period 07/04/2022 - 11/12/2026)

Establishment Labs Inc (ESTA) - metric breakdowns and financial figures

Brand item of establishmentlabs.com

For the bioengineering business Establishment Labs (ESTA), which develops high-tech implants with RFID chips, the company's forward P/E chart serves as an indicator of market expectations. This metric compares current market capitalization with expected earnings, reflecting the cost per unit of future profit. Mathematically, it captures the stock price reaction to the Federal Reserve's tight monetary policy. A compression of the multiple signals a reassessment of risks, while a decline in the indicator amid high interest rates may indicate capital stagnation.

Competitors of Establishment Labs

Future Price to Earnings Boston Scientific Corporation (BSX)|Future Price to Earnings EW (Edwards)|Forward P/E Multiple RMD (ResMed Corp)|Market Cap to Projected Earnings Insulet Inc. (PODD)|ZBH: Projected Price to Earnings|Price to Expected Earnings Ratio COO|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Inc (GMED)|TMDX (TransMedics Group) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec Corp)|Projected Price to Earnings AORT (Artivion, Inc.)|ENOV (enovis.com) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Holdings Corporation IART|BBNX - Projected Price to Earnings|Iradimed - Forward P/E Multiple|Projected Price to Earnings Ratio Embecta Health|TNDM: Forward P/E Multiple|Price to Future Earnings Ratio AXGN|SIBN (SI-BONE) - Forward P/E Multiple|Orthofix Medical (OFIX) - Market Cap to Projected Earnings|Forward P/E Multiple BVS|Projected Price to Earnings orthopediatrics.com KIDS|Forward P/E Multiple TMCI (Treace Medical Concepts)|Forward P/E Multiple blade.com SRTA|CARL - Future Price to Earnings|RXST: Future Price to Earnings|CLPT (clearpointneuro.com) - Projected Price to Earnings|Stereotaxis Corporation - Future Price to Earnings Multiple|STIM (Neuronetics, Inc.) - Forward P/E Multiple|Projected Price to Earnings Ratio sightsciences.com SGHT|Future Price to Earnings Orchestra BioMed, Inc. (OBIO)|anikatherapeutics.com (ANIK) - Forward Price to Earnings Multiple|InspireMD Corp - Projected Price to Earnings|Forward P/E Multiple Jin Medical International Ltd. ZJYL|Vivani - Forward P/E Multiple|Market Cap to Projected Earnings Xtant Medical Holdings XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Future Price to Earnings|Price to Expected Earnings Ratio MODD (Modular Medical, Inc.)|Future Price to Earnings Myomo, Inc|Projected Price to Earnings Envoy Medical Inc (COCH)|Forward P/E Multiple VVOS|NVNO - Projected Price to Earnings Ratio|Future Price to Earnings Sintx Technologies, Inc. SINT|TNON: Price to Future Earnings Ratio|LFWD: Projected Price to Earnings|Autonomix Medical, Inc. - Market Cap to Future Earnings Ratio|IVF: Forward P/E Multiple|Projected Price to Earnings Ratio bonebiologics.com (BBLG)|Future Price to Earnings Axonics|BIOLASE Inc. (BIOL) - Market Cap to Projected Earnings|Projected Price to Earnings DYNT (Dynatronics Corporation)|Market Cap to Future Earnings Ratio FNA|Forward P/E Multiple INVO (INVO Bioscience)